Format

Send to

Choose Destination
See comment in PubMed Commons below
J Urban Health. 2003 Jun;80(2):288-90.

Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City.

Author information

1
Center for Urban Epidemiologic Studies at the New York Academy of Medicine, USA. pcoffin9@itsa.ucsf.edu

Abstract

Preliminary research suggests that naloxone (Narcan), a short-acting opiate antagonist, could be provided by prescription or distribution to heroin users to reduce the likelihood of fatality from overdose. We conducted a random postal survey of 1100 prescription-authorized health care providers in New York City to determine willingness to prescribe naloxone to patients at risk of an opiate overdose. Among 363 nurse practitioners, physicians, and physician assistants responding, 33.4% would consider prescribing naloxone, and 29.4% were unsure. This preliminary study suggests that a substantial number of New York City health care providers would prescribe naloxone for opiate overdose prevention.

PMID:
12791804
PMCID:
PMC3456271
DOI:
10.1093/jurban/jtg031
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer Icon for PubMed Central
    Loading ...
    Support Center